First Manhattan’s West Pharmaceutical WST Stock Holding History

First Manhattan’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,823	Closed	-$836K	–	742
2025 Q2	$836K	Buy	+3,823	New	+$817K	﹤0.01%	449
2024 Q2	–	Sell	-529	Closed	-$209K	–	1347
2024 Q1	$209K	Hold	529	–	–	﹤0.01%	649
2023 Q4	$186K	Hold	529	–	–	﹤0.01%	654
2023 Q3	$198K	Hold	529	–	–	﹤0.01%	660
2023 Q2	$202K	Hold	529	–	–	﹤0.01%	662
2023 Q1	$183K	Hold	529	–	–	﹤0.01%	692
2022 Q4	$125K	Sell	529 -529	-50%	-$125K	﹤0.01%	796
2022 Q3	$260K	Hold	1,058	–	–	﹤0.01%	642
2022 Q2	$319K	Hold	1,058	–	–	﹤0.01%	618
2022 Q1	$434K	Hold	1,058	–	–	﹤0.01%	604
2021 Q4	$496K	Buy	+1,058	New	+$455K	﹤0.01%	575
2021 Q3	–	Sell	-17	Closed	-$6K	–	1699
2021 Q2	$6K	Buy	+17	New	+$5.62K	﹤0.01%	1369
2016 Q2	–	Sell	-2,800	Closed	-$194K	–	1528
2016 Q1	$194K	Hold	2,800	–	–	﹤0.01%	671
2015 Q4	$168K	Hold	2,800	–	–	﹤0.01%	711
2015 Q3	$151K	Hold	2,800	–	–	﹤0.01%	721
2015 Q2	$162K	Hold	2,800	–	–	﹤0.01%	735
2015 Q1	$168K	Hold	2,800	–	–	﹤0.01%	724
2014 Q4	$149K	Hold	2,800	–	–	﹤0.01%	752
2014 Q3	$125K	Hold	2,800	–	–	﹤0.01%	775
2014 Q2	$118K	Buy	+2,800	New	+$120K	﹤0.01%	780
2014 Q1	–	Sell	-6,897	Closed	-$338K	–	1460
2013 Q4	$338K	Buy	+6,897	New	+$323K	﹤0.01%	581

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

First Manhattan's WST Position: Q3 2025 in Review

First Manhattan sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 3,823 shares — an estimated $836K sold.

First Manhattan first reported a position in WST in Q4 2013 and held it in 21 quarters. The position peaked at $836K in Q2 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

First Manhattan reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
First Manhattan sold 3,823 West Pharmaceutical shares in Q3 2025, an estimated $836K.
First Manhattan first reported a position in West Pharmaceutical in Q4 2013 and held it in 21 quarters.
First Manhattan's West Pharmaceutical position peaked at $836K in Q2 2025.
758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on First Manhattan's 13F filing for Q3 2025, filed 14 Nov 2025.